Deng Qinjian said constellation _ Deng Xingping sword

Some friends who work here talk about the treatment of Yifeng Pharmacy.

Yifeng pharmacy chain co., ltd

Company code: 603939 Company abbreviation: Yifeng Pharmacy

2020

First quarter report

First of all, important tips

1. 1 The board of directors, board of supervisors, directors, supervisors and senior management of the Company guarantee that the quarterly report is true, accurate and complete, and there are no false records, misleading statements or major omissions, and they shall bear individual and joint legal responsibilities for it.

1.2 all directors of the company attended the board meeting to review the quarterly report.

1.3 Gao Yi, the person in charge of the company, Deng, the person in charge of accounting work, and Guan Changfu, the person in charge of the accounting institution (accounting supervisor), guarantee the truthfulness, accuracy and completeness of the financial statements in the quarterly report.

1.4 the company's first quarter report was unaudited.

II. Major financial data of the company and changes of shareholders

2. 1 main financial data

Unit: Yuan Currency: RMB

■

Non-recurring profit and loss items and amounts

√ Applicable □ Not applicable

Unit: Yuan Currency: RMB

■

2.2 Description of the total number of shareholders, the top ten shareholders and the top ten tradable shareholders (or shareholders with unlimited sales conditions) as of the end of the reporting period.

Unit: shares

■

2.3 Table of the total number of preferred shareholders, the top ten preferred shareholders and the top ten unrestricted tradable shareholders as of the end of the reporting period.

□ Applicable √ Not applicable.

Three. material particulars

3. 1 Major changes in the items and financial indicators of the company's accounting statements and their causes.

√ Applicable □ Not applicable

■

3.2 Analysis and explanation of the progress, impact and solutions of important matters.

√ Applicable □ Not applicable

(1) Newly added stores in the reporting period:

By March 3rd, 2020, the company had 4,869 stores (including 4 19 franchise stores) with a total operating area of 53 1 4,445 square meters (excluding franchise stores). In March 2020, the company added 1650 stores. The regional distribution is as follows:

■

(II) Operating efficiency of the company's direct stores during the reporting period.

By March 3, 2020, there were 4,450 direct stores, and the operating efficiency of direct stores was as follows:

■

Description:

1, daily average efficiency = daily average operating income/store operating area.

2. Average daily operating income = business income including tax in the current year of the store/business days in the current year of the store.

3. Xuzhou Enqi 3 1 Store completed the equity change on March 3 1 Day, and no operating income was generated in the first quarter, and the floor effect was not calculated.

(III) Mergers and acquisitions in the same industry during the reporting period

During the reporting period, the company implemented 1 mergers and acquisitions in the same industry. Details are as follows:

20 19 June, Jiangsu Yifeng, a wholly-owned subsidiary of the company, and Ding Peisheng signed the Framework Agreement on Reorganization and Acquisition of Xuzhou Enqi Pharmaceutical Chain Co., Ltd., and acquired 65% equity of the newly established company, with 24.7 million equity transfer price, involving 3/kloc-0 stores. The project was completed in March 2020.

(D) the progress of convertible corporate bonds

In April, 2020, the company received the Reply of China Securities Regulatory Commission on Approving Yifeng Pharmacy Chain Co., Ltd. to issue convertible corporate bonds in public (ZJK [2020] No.593). For details, please refer to the Announcement on Approving the Public Issuance of Convertible Bonds by China Securities Regulatory Commission, which was disclosed in the statutory disclosure media on April 10, 2020.

3.3 Unfulfilled commitments during the reporting period.

□ Applicable √ Not applicable.

3.4 Early warning and explanation of the reasons for predicting that the accumulated net profit from the beginning of the year to the end of the next reporting period may be a loss or a significant change compared with the same period of last year.

□ Applicable √ Not applicable.

Company name: Yifeng Pharmacy Chain Co., Ltd.

Legal Representative: Gao Yi

Date: April 2020 14.

Securities Code: 603939 Securities Abbreviation: Yifeng Pharmacy AnnouncementNo.: 2020-024

Yifeng pharmacy chain co., ltd

Announcement of main operating data in the first quarter of 2020

The board of directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and they shall bear individual and joint responsibilities for the truthfulness, accuracy and completeness of its contents.

According to the relevant requirements of the Guidelines for Information Disclosure of Listed Companies by Industry and the Notice on Doing a Good Job in the Report Disclosure of Listed Companies in the First Quarter of 2020 issued by Shanghai Stock Exchange, the main operating data of Yifeng Pharmacy Chain Co., Ltd. (hereinafter referred to as "the Company") in the first quarter of 2020 are disclosed as follows:

I. Main operating data at the end of the reporting period

1, main accounting data

Unit: Yuan Currency: RMB

■

2. Main business is divided into industries, products and regions.

Unit: Yuan Currency: RMB

■

[Note1]: In the first quarter of 2019, the income and cost of retail business included the income and cost of distribution to franchisees. Now, due to the increasing number of franchisees, the income and cost of distribution to franchisees will be classified as wholesale business during the reporting period. If the income and cost distributed to franchisees in the same period last year are classified as wholesale business, that is, the comparison caliber will be the same, then the income and business of retail business will be the same during the reporting period. Operating income, operating cost and gross profit margin of wholesale business increased or decreased by 103. 14%, 1 10.69% and -3.29% respectively compared with the same period of last year.

[Note 2]: Central and South China includes: Hunan Province, Hubei Province and Guangdong Province; East China includes: Jiangsu, Shanghai, Zhejiang and Jiangxi provinces; North China includes: Hebei Province and Beijing.

Two. Changes of stores during the reporting period

1. Store expansion.

By March 3rd, 2020, the company had 4,869 stores (including 4 19 franchise stores) with a total operating area of 53 1 4,445 square meters (excluding franchise stores). In March 2020, the company added 1650 stores. The regional distribution is as follows:

■

Note: Central and South China includes: Hunan Province, Hubei Province and Guangdong Province; East China includes: Jiangsu, Shanghai, Zhejiang and Jiangxi provinces; North China includes: Hebei Province and Beijing.

2. Direct stores are eligible for medical insurance.

By March 3rd, 2020, the company had 4,450 direct chain stores and 3,503 pharmacies qualified as "designated retail pharmacies for medical insurance", accounting for 78.72% of the total number of stores in the company.

■

It is hereby announced.

Yifeng Pharmacy Chain Co., Ltd. Board of Directors

April 2020 15